Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Cost-effectiveness of screening, decolonisation and isolation strategies for carbapenem-resistant Enterobacterales and methicillin-resistant Staphylococcus aureus infections in hospitals: a sex-stratified mathematical modelling study
Indexado
WoS WOS:001428857900001
Scopus SCOPUS_ID:85217886680
DOI 10.1016/J.LANA.2025.101019
Año 2025
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Background Methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacterales (CRE) impose the greatest burden among critical bacterial pathogens. Evidence for sex differences among antibiotic resistant bacterial infections is increasing but a focus on policy implications is needed. We assessed impact of CRE/MRSA on excess length of hospital stay, intensive care unit admission, and mortality by sex from a retrospective cohort study (n = 873) of patients in three Chilean hospitals, 2018-2021. Methods We used inverse-probability weighting combined with descriptive, logistic, and competing-risks analyses. We developed a sex-stratified deterministic compartmental model to analyse hospital transmission dynamics and the cost-effectiveness of nine interventions. We compared interventions based on the incremental costeffectiveness ratio (ICER) per quality-adjusted life year (QALY) gained and estimated net benefits. Findings The adjusted odds of women acquiring CRE and MRSA were 0.44 (0.28-0.70; p = 0.0013) and 0.73 (95% CI = 0.48-1.01; p = 0.050), respectively. Competing-risk models indicated higher mortality rates among women, compared to men. Mathematical model projections showed that pre-emptive isolation across all newly admitted high-risk men was the most cost-effective intervention (ICER = $1366/QALY and $1083/QALY for CRE and MRSA, respectively). Chromogenic agar coupled with MRSA decolonisation was the second most cost-effective intervention ($2099/QALY), followed by screening plus isolation or pre-emptive isolation strategies (ICER ranged between $2411/QALY and $4216/QALY across CRE and MRSA models). Probabilistic sensitivity analysis showed that strategies were ICER < willingness-to-pay in 80% of simulations, except for testing plus digestive decolonisation for CRE. At a 20% national hospital coverage at least $12.2 million could be saved. Interpretation Our model suggests that targeted infection control strategies would effectively address rising CRE and MRSA infections. Maximising health-economic gains may be achieved by focusing on control measures for men as primary drivers for transmission, thereby reducing the disproportionate disease burden borne by women. Copyright (c) 2025 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Revista



Revista ISSN
2667-193X

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Public, Environmental & Occupational Health
Health Care Sciences & Services
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Allel, Kasim Hombre UNIV OXFORD - Reino Unido
Pontificia Universidad Católica de Chile - Chile
London Sch Hyg & Trop Med - Reino Unido
University of Oxford Medical Sciences Division - Reino Unido
London School of Hygiene &amp; Tropical Medicine - Reino Unido
London School of Hygiene & Tropical Medicine - Reino Unido
2 Garcia, Patricia - Pontificia Universidad Católica de Chile - Chile
3 Peters, Anne Mujer Universidad del Desarrollo - Chile
4 MUNITA-SEPULVEDA, JOSE MANUEL Hombre Universidad del Desarrollo - Chile
5 Undurraga, Eduardo A. - Pontificia Universidad Católica de Chile - Chile
Centro de Investigación para la Gestión Integrada del Riesgo de Desastres (CIGIDEN) - Chile
6 Yakob, Laith - London Sch Hyg & Trop Med - Reino Unido
London School of Hygiene &amp; Tropical Medicine - Reino Unido
London School of Hygiene & Tropical Medicine - Reino Unido

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
Fondo Nacional de Desarrollo Científico y Tecnológico
Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias
ANID Fondecyt
Agencia Nacional de Investigación y Desarrollo
Agencia Nacional de Investigacion y Desarrollo ANID, Chile
Beca de Doctorado en el Extranjero
Royal Society of Tropical Medicine and Hygiene

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
Agencia Nacional de Investigacion y Desarrollo ANID, Chile.
Agencia Nacional de Investigaci\u00F3n y Desarrollo ANID, Chile.We thank the Agencia Nacional de Investigaci\u00F3n y Desarrollo ANID through the Fondo Nacional de Desarrollo Cient\u00EDfico y Tecnol\u00F3gico FONDECYT Grants 1211933 (to PG, JM, EU), Beca de Doctorado en el Extranjero Becas Chile 2020 Grant 72210084 (to KA), and Royal Society of Tropical Medicine and Hygiene (RSTMH) for its support through the 2021 early career grant award (KA). We also thank ANID FONDECYT and FONDAP (Grant numbers: 1242022 and 1522A0005 to EU).
Agencia Nacional de Investigaci\u00F3n y Desarrollo ANID, Chile.We thank the Agencia Nacional de Investigaci\u00F3n y Desarrollo ANID through the Fondo Nacional de Desarrollo Cient\u00EDfico y Tecnol\u00F3gico FONDECYT Grants 1211933 (to PG, JM, EU), Beca de Doctorado en el Extranjero Becas Chile 2020 Grant 72210084 (to KA), and Royal Society of Tropical Medicine and Hygiene (RSTMH) for its support through the 2021 early career grant award (KA). We also thank ANID FONDECYT and FONDAP (Grant numbers: 1242022 and 1522A0005 to EU).

Muestra la fuente de financiamiento declarada en la publicación.